Literature DB >> 31028490

Investigation of Effect of Isopropyl Palmitate on Drug Release from Transdermal Patch and Molecular Dynamics Study.

Jiuheng Ruan1, Xiaocao Wan1, Peng Quan1, Chao Liu1, Liang Fang2.   

Abstract

Chemical penetration enhancers are widely used in transdermal drug delivery system. However, few studies have focused on changes of concentration in chemical penetration enhancers. In this study, the effect of concentrations of enhancers on drug release and its mechanism were investigated. Zolmitriptan (ZOL) was used as a model drug and isopropyl palmitate (IPP) was used as a model enhancer to investigate drug release behaviors in pressure-sensitive adhesives (PSAs). The IPP concentrations were 2, 5, 10, 12, and 15%. Drug release percents increased by 4.8, 11.5, 16, 15.1, and 14.8%, respectively. Interestingly, the linear relationship between concentrations of IPP and release percents was improved in the 0-10% and remained unchanged in the 10-15%. Moreover, thermal and rheology studies were performed to investigate changes of the fluidity of PSAs. FT-IR and molecular dynamics simulation were conducted to confirm the interaction strength among ZOL, IPP, and PSAs. The results elucidated that IPP increased fluidity of PSAs and vied for drug from PSAs. As a result, the interaction among three components played a major role in changing release behaviors of ZOL, but the increased fluidity only worked in the concentration of less than 10%.

Entities:  

Keywords:  drug release; fluidity; isopropyl palmitate; molecular interaction; zolmitriptan

Mesh:

Substances:

Year:  2019        PMID: 31028490     DOI: 10.1208/s12249-019-1370-7

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  2 in total

Review 1.  Percutaneous Delivery of Antihypertensive Agents: Advances and Challenges.

Authors:  Kevin Ita; Sharon Ashong
Journal:  AAPS PharmSciTech       Date:  2020-01-06       Impact factor: 3.246

2.  Predicting transdermal fentanyl delivery using physics-based simulations for tailored therapy based on the age.

Authors:  Flora Bahrami; René Michel Rossi; Thijs Defraeye
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.